Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Tai, Yu-Tzu
Item TypeName
Academic Article Myeloma-specific multiple peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma and other plasma cell disorders.
Academic Article Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration.
Academic Article Antibody therapy in multiple myeloma
Academic Article The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome.
Academic Article Potent in vitro and in vivo activity of an Fc-engineered humanized anti-HM1.24 antibody against multiple myeloma via augmented effector function.
Academic Article Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders.
Concept Leukemia, Plasma Cell
Concept Plasma Cells
Academic Article Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patients.
Academic Article Widespread intronic polyadenylation diversifies immune cell transcriptomes.
Academic Article Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1.
Academic Article Monitoring the cytogenetic architecture of minimal residual plasma cells indicates therapy-induced clonal selection in multiple myeloma.
Academic Article Primary Plasma Cell Leukemia: Real-World Retrospective Study of 46 Patients From a Single-Center Study in China.
Search Criteria
  • Plasma Cells
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.